loader
Please Wait
Applying Filters...
menu
    • menu

    Finished Formulations with L-leucine

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Leucine

    INACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 4CABERGOLINE

    02 1LINZESS

    03 1MUPIROCIN

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers

    01

    ABBVIE
    U.S.A
    arrow
    Discovery on Target
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    LINACLOTIDE

    Drug : LINZESS

    Dosage Form : CAPSULE; ORAL

    Application Number : 202811

    Country : US

    Patented : Yes

    Abbvie Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    ACTAVIS LABS FL INC

    Cabergoline

    Discovery on Target
    Not Confirmed
    arrow

    03

    APOTEX CORP

    Cabergoline

    Discovery on Target
    Not Confirmed
    arrow

    04

    GLENMARK PHARMS

    Mupirocin

    Discovery on Target
    Not Confirmed
    arrow

    05

    IVAX SUB TEVA PHARMS

    Cabergoline

    Discovery on Target
    Not Confirmed
    arrow

    06

    NORVIUM BIOSCIENCE

    Cabergoline

    Discovery on Target
    Not Confirmed
    arrow
    NORVIUM BIOSCIENCE
    arrow
    Discovery on Target
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    CABERGOLINE

    Drug : CABERGOLINE

    Dosage Form : TABLET; ORAL

    Application Number : 202947

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF